Company profile
Viracta Therapeutics, Inc. Insider Trading
VIRXEvery SEC Form 4 insider trading filing for Viracta Therapeutics, Inc. (VIRX) since April 2023: open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?
- Sector
- Pharmaceutical Preparations
- CIK
- 0001061027
- Filings
- 43
- Insiders
- 13
- Last filing
- 2024-11-25
Activity summary
No insider transactions in the last 30 days. The most recent was on November 25, 2024, when Roger Pomerantz bought 9,034 shares. 43 filings from 13 insiders are on record below.
Quarterly balance
Buy and sell value by quarter, Q2 23 to Q4 24. Viracta Therapeutics, Inc. insiders are net buyers across the period shown.
Bars below the rule are sales, above are purchases. Largest quarter on the chart is $49K.
No insider activity recorded for VIRX in the last 90 days.
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Nov 25, 2024 | Roger Pomerantz | VIRX | Option Exercise | 9,034 | — | — |
| Nov 25, 2024 | Roger Pomerantz | VIRX | Option Exercise | 9,034 | — | — |
| Nov 25, 2024 | Ivor Royston | VIRX | Option Exercise | 25,219 | — | — |
| Nov 25, 2024 | Ivor Royston | VIRX | Option Exercise | 25,219 | — | — |
| Aug 25, 2024 | Roger Pomerantz | VIRX | Option Exercise | 9,034 | — | — |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Query this yourself
The same rows, over the API.
curl "https://api.form4api.com/v1/transactions?ticker=VIRX" \
-H "X-Api-Key: $KEY"Top insiders
By total value filed.